MiNK Therapeutics Inc

NASDAQ:INKT   9:30:00 AM EDT
7.36
-0.03 (-0.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MiNK Therapeutics Inc Stock, NASDAQ:INKT

149 5th Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8250
Number of Employees: 23
http://www.minktherapeutics.com

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.